4.82
price down icon4.74%   -0.24
after-market Handel nachbörslich: 4.77 -0.05 -1.04%
loading

Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
5.61%
2.2697
2.1492 2.7818 2.8216 4.1218
Operating Income/Loss
4.28%
-2.2697
-2.1765 - - -
Income/Loss From Continuing Operations Before Tax
4.52%
-2.2463
-2.1492 -2.7818 -2.8216 -4.1218
Income/Loss From Continuing Operations After Tax
4.52%
-2.2463
-2.1492 -2.7818 -2.8216 -4.1218
Net Income/Loss
4.52%
-2.2463
-2.1492 -2.7818 -2.8216 -4.1218
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
94.06%
1.1903
20.04 0.2556 16.36 15.82
Diluted Average Shares
94.06%
1.1903
20.04 0.2556 16.36 15.82
Basic Earnings Per Share
1,618%
-1.89
-0.11 -0.16 -0.17 -0.26
Diluted Earnings Per Share
1,618%
-1.89
-0.11 -0.16 -0.17 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):